🥇 First rule of investing? Know when to save! Up to 55% off Investing Pro before BLACK FRIDAYCLAIM SALE

Earnings call: IMAX exceeds Q3 expectations with strong financials

EditorNatashya Angelica
Published 10/31/2024, 11:10 AM
© Reuters.
IMAX
-

IMAX Corporation (NYSE: NYSE:IMAX) reported robust financial results in its Q3 2024 earnings call, with CEO Rich Gelfond and CFO Natasha Fernandes providing insights into the company's performance and future prospects. IMAX exceeded market expectations, with an adjusted EBITDA of $39 million, representing a 42% margin, and earnings per share (EPS) of $0.35, surpassing forecasts by over 50%.

The company has seen a significant increase in system installations and expects to end the year within the high end of the 130-150 range. With a strong film slate, IMAX anticipates a global box office exceeding $1.2 billion in 2025.

Key Takeaways

  • IMAX's adjusted EBITDA reached $39 million with a 42% margin.
  • Earnings per share (EPS) were reported at $0.35, over 50% higher than expected.
  • 100 systems have been installed year-to-date, with a forecast to reach 130-150 by year-end.
  • The Q3 global box office showed a 45% increase compared to 2019.
  • Revenue for Q3 stood at $91.5 million, driven by major titles and content solutions.
  • IMAX anticipates over $1.2 billion in global box office by 2025, bolstered by a strong film slate.
  • The company is diversifying its content and expanding its market presence, with a focus on local language projects.

Company Outlook

  • IMAX's capital position is robust with $105 million in cash and $280 million in debt.
  • Liquidity exceeds $410 million, with a $30 million investment in CapEx planned.
  • The company has repurchased $18 million in shares year-to-date.
  • IMAX is optimistic about future growth, driven by increasing demand for the IMAX experience.

Bearish Highlights

  • System rentals saw a decline, prompting a discussion on strategies for maximizing returns.
  • Despite a challenging economic environment in China, there is hope for improvement in box office performance in 2025.

Bullish Highlights

  • A strong demand for film slots, with no availability from May to September 2024.
  • 14 films slated for release in 2025 were shot with IMAX cameras, indicating a robust film pipeline.
  • Increased certainty in theatre and film backlogs could lead to a lower discount rate for future cash flows.

Misses

  • The company is addressing the decline in system rentals and the economic challenges in China.

Q&A Highlights

  • Gelfond addressed concerns about superhero fatigue, emphasizing a well-balanced film slate.
  • Fernandes clarified that the $1.2 billion revenue projection for 2025 is based on a comprehensive view of the company's financials.
  • The company is exploring various revenue models, including flat fee deals, to strengthen financials.
  • Gelfond noted the potential of IMAX's 1,800 theatres to showcase diverse experiences beyond movies.

IMAX Corporation continues to demonstrate financial strength and growth potential. With a strategic focus on content diversification, technological enhancements, and market expansion, the company is well-positioned to capture the increasing demand for the IMAX experience. Despite the challenges faced in certain markets, IMAX's leadership remains confident in the company's ability to navigate and thrive in the dynamic entertainment landscape.

InvestingPro Insights

IMAX Corporation's strong Q3 2024 performance is reflected in its recent market performance and financial metrics. According to InvestingPro data, IMAX has seen a significant return over the last week, with a 1-week price total return of 8.02%. This aligns with the company's robust earnings report and positive outlook shared during the earnings call.

The company's financial health is further underscored by InvestingPro Tips, which indicate that IMAX operates with a moderate level of debt and its liquid assets exceed short-term obligations. This supports the CFO's statement about the company's robust capital position, with $105 million in cash and $280 million in debt.

IMAX's price-to-earnings (P/E) ratio stands at 53.73, which may seem high at first glance. However, an InvestingPro Tip suggests that IMAX is trading at a low P/E ratio relative to its near-term earnings growth. This is supported by the company's PEG ratio of 0.14, indicating that the stock may be undervalued considering its growth prospects.

The company's profitability, as mentioned in the earnings call, is reinforced by InvestingPro data showing a gross profit margin of 55.79% for the last twelve months as of Q2 2024. This robust margin aligns with IMAX's reported adjusted EBITDA margin of 42% for Q3.

For investors seeking more comprehensive analysis, InvestingPro offers 11 additional tips for IMAX, providing a deeper understanding of the company's financial position and market performance.

Full transcript - Imax corporation (IMAX) Q3 2024:

Operator: Good day and thank you for standing by. Welcome to the Q3 2024 IMAX Corporation's Earnings Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. [Operator Instructions]. Please be advised that today's conference is being recorded. I would now like to hand the call over to Jennifer Horsley, Head of Investor Relations for IMAX. Jennifer, you have the floor.

Jennifer Horsley: Good afternoon and thank you for joining us for IMAX's third quarter 2024 earnings conference call. On the call today to review the financial results are Rich Gelfond, Chief Executive Officer and Natasha Fernandes, our Chief Financial Officer. Rob Lister, Chief Legal Officer is also joining us today. Today's conference call is being webcast in its entirety on our website. A replay of the webcast will be made available shortly after the call. In addition, the full text of our earnings press release and the slide presentation have been posted on the Investor Relations section of our site. Our historical Excel model is posted to the website as well. I would like to remind you of the following information regarding forward-looking statements. Today's call, as well as the accompanying slide deck may include statements that are forward looking and that pertain to future results or outcomes. These forward-looking statements are subject to risks and uncertainties that could cause our actual future results to not occur or occurrences to differ. Please refer to our SEC filings for a more detailed discussion of some of the factors that could affect our future results and outcomes. Any forward-looking statements that we make on this call are based on assumptions as of today and we undertake no obligation to update these statements as a result of new information, future events or otherwise. During today's call, references may be made to certain non-GAAP financial measures. Discussion of management's use of these measures and the definition of these measures, as well as a reconciliation to non-GAAP financial measures are contained in this afternoon's press release and our earnings materials which are available on the Investor Relations page of our website at imax.com with that, let me now turn the call over to Mr. Richard Gelfond. Rich?

Richard Gelfond: Thanks Jennifer and thanks everyone for joining today. IMAX is setting the table what we believe to be a new sustained era of growth over the next several years. Moviegoing has rebounded after the Hollywood strikes ahead of a phenomenal slate in 2025 and 2026. Exhibitor demand for IMAX is surging, with system sales and installations significantly outpacing 2023. We expect 2025 to be our best year ever at the global box office with more than $1.2 billion and Imax grosses worldwide. The fundamental measures of growth in our business system installations, timings and the content pipeline are all strong and this came to the fore in the third quarter. We beat consensus estimates with adjusted EBITDA of $39 million at a 42% margin and EPS of $0.35, beating the street by over 50%. We've already installed 100 systems worldwide year-to-date, including one of our best third quarters ever. We are now tracking to hit the high end of our installation guidance, which we raised last quarter to between 130 and 150 systems. This year we signed agreements for 119 IMAX systems worldwide year-to-date on track to deliver more than 129 we completed in 2023. We delivered one of our best third quarters ever at the global box office, driven by domestic box Office that exceeded 2019 by 45%. These results are noteworthy given the tough comp versus Oppenheimer in 2023 Q3. Network expansion offset box office softness, further demonstrating our diversified revenue base and flexible asset light business model. More than anything, we're focused on the future. The '25 and '26 slates look as strong as we've ever seen with releases from the biggest filmmakers and most successful franchises from Avatar to Avengers. 2025 alone boasts at least 14 films for IMAX releases worldwide. Hollywood and local language, films shot without cameras specifically for our screens. We typically index much higher with these titles, and as reported, we're very excited to be working with our long-standing partners Christopher Nolan and Emma Thomas on the release of their Next film in July 2026. I'm pleased to share that Chris will be utilizing new IMAX technology in the making of the film, never before used equipment that our teams have been developing throughout this past year. As filmmakers and studios lean into our technology, moviegoers worldwide drive our global box office and market share and exhibitors install more of our systems to meet consumer demand. An influx of great content will only accelerate these trends and we look forward to executing to deliver results for our business and our shareholders. Today I'd like to offer updates on the opportunity we see ahead in our global network and our content slate. Then I'll hand it over to Natasha before we both take your questions. First momentum continued to build in our global network with strong installations and sales activity in the third quarter. We completed 49 installations in the third quarter alone, compared to 30 for the same period in 2023. And we made progress in priority markets around the world with signings in France, Australia and Saudi Arabia. Our recent agreement with Movie, Saudi Arabia's largest exhibitor puts us in business with the four top exhibitors in the Kingdom. Saudi moviegoers continue to embrace a variety of IMAX content, from Oppenheimer to Bad Boys 4 to Indian and Japanese titles. We are pursuing our first local language project in Saudi, which will make the IMAX platform even more attractive to local exhibitors. We see an opportunity to expand IMAXs Saudi footprint from the 10 currently in operation to at least 50 in the years ahead. Around the world conversations with existing and new exhibition partners are robust. Already in the fourth quarter, we've completed agreements with partners in Australia, Japan and Latin America. And in the wake of our landmark deal with Wanda Film, we're seeing encouraging signs of progress at the Chinese box office. China has lagged the rest of the world in 2024, but as we look ahead, we have reason for optimism. Next year's Hollywood slate is more consistent with the diversity of tentpoles and franchises that have historically resonated with Chinese audiences, as demonstrated by this weekend's Venom: The Last Dance and Alien: Romulus, which delivered greater IMAX box office in China than it did in the US there is still a market for distinctive Hollywood films there. A local language slate next year looks promising, starting with Chinese New Year, which is set to feature big blockbuster titles initially slated for this year. And China is in the process of rolling out an economic stimulus package to bolster consumer confidence in the economy. We saw progress during the October national holiday, where our daily box office returns and market share grew year-over-year despite a relatively soft slate. China also offers fertile testing ground as we open our aperture with new IMAX events and experiences. We are live streaming the 2024 League of Legends World Championship, an online multiplayer battle video game which is among the world's largest esports across more than 70 IMAX locations in China. League of Legends is published by Tencent, owns Riot Games, and Tencent is also a major investor in RUI Holdings. Our partners that own Wanda Film, our streaming and consumer technology division, is testing a new proprietary technology with the potential to rapidly expand our connected live network without the considerable capex necessary to wire our locations. We successfully tested this technology with our sell out presentation of the NBA Finals in Hong Kong and Taiwan early this year, and we see an opportunity to efficiently scale our global connected network and we'll continue to explore unique live events as we enter the new year. We're seeing strong momentum across our content portfolio and pipeline. While many initially tagged 2024 as a recovery year, the global box office is showing encouraging signs of progress sooner than many anticipated. We delivered more than $83 million with Deadpool and Wolverine alone. That's more than a 50% better than any previous installment in the franchise and good for our fifth highest Marvel title of all time. Last weekend's Venom: The Last Dance, a film for IMAX release, delivered a strong international opening led by China, resulting in one of our best ever October debuts globally. And we strategically managed our network to accommodate a diverse, promising slate of tentpoles this Thanksgiving and through the holidays, including Gladiator 2, Wicked, Moana 2 and Mufasa the Lion King. It's a great on ramp for what looks set to be a very special year ahead. Every IMAX release currently scheduled from May through September is filmed with IMAX cameras. That includes Mission Impossible 8, Marvel's Thunderbolts, F1 and Superman Legacy. The strong, consistent slate concludes with Avatar 3, the follow up to our highest grossing films of all time. 2026 kicks off with Avatar Carryover and includes new installments of major franchises including Avengers, Star Wars, the Batman, Super Mario Brothers and Toy Story alongside our expanding portfolio of local language documentaries and events. IMAX powers, Awe inspiring experiences we are opening our content aperture to deliver new experiences for our audiences and drive capacity utilization of our network. We recently hired our first Chief Content Officer to coordinate our content portfolio across Hollywood, local language docs, live and new events and experiences and fine tune our strategy as our portfolio grows to more than 100 experiences per year. We've had successes this year with a more consistent pipeline of experiences beyond first run theatrical releases nearly quadruple the output of the previous year. That includes a balanced mix of music including Queen Rock's Machi Ho and a recent concert hit in South Korea, I’m Hero, which is now our highest grossing local language title of any kind. In that market, documentaries, both originals like Blue Angels and through distribution partnership with companies including Netflix (NASDAQ:NFLX) and NatGeo, as well as library content events. Most notably our partnership with A24 to release one of their iconic films each month during an underutilized weekday. We also continue to push the envelope in experimentation with new experiences like the Paris Olympics, Opening Ceremony and League of Legends. We remain in talks with NBC Universal on additional sports and entertainment events as well as tonight's launch event of Amazon (NASDAQ:AMZN) Prime's new concert film with hip hop artist Megan Thee Stallion, which builds on a successful launch of Prime's hit series Fallout earlier this year. To close we are building momentum at the right time for our business with our system installations and sales activity ahead of expectations years to date and a 2024 slate that on balance has delivered. Consumers continue to prove that, when there are awe inspiring events that fully capitalize on the IMAX experience, they will show up and we have a fuller, more promising slate over the next two years and beyond than we've ever seen. We continue to believe we are entering a very exciting time for our business and we look forward to continuing to deliver results in our business and for our shareholders. Thank you again and with that I'll turn it over to Natasha.

Natasha Fernandes: Thanks Rich and Good afternoon, everyone. Q3 demonstrated once again the resiliency in our business as we delivered strong results while managing through some top line headwinds including the challenging compare to last year's record Oppenheimer performance. Adjusted EBITDA came in at $39 million and a margin of 42% above our high 30s percent full year guidance. System installations are accelerating and outpacing our normal seasonality with 49 systems in the quarter, an increase of 63% year-over-year. As a result, installations are now tracking to come in at the high end of our full year guidance range of 130 to 150 systems, as Rich highlighted. At the same time, profitability and cash flows remain Strong. We delivered EPS of $0.26, an increase of 18% year-over-year and operating cash flows of $35 million, an increase of 21% year-over-year. Overall, our results reflected our growing business momentum and management's continued focus on efficiencies and operating expense reductions. Looking forward, the table is set for accelerating revenue and profitability from the combination of our growing network footprint and in improving Hollywood and local language box offices. In addition to expecting over $1.2 billion in IMAX box office in 2025, we also expect our box office to continue this upward growth trajectory over the next several years given our strong position in the industry, the promising Hollywood box office slate that we either have scheduled or have visibility into, as well as our expected network growth. The bottom-line picture improves further as the operating leverage that comes with higher box office and scale increases and we look to increase utilization by bringing other content onto our platform and deploying more digital marketing initiatives while also working to scale our streaming consumer and technology business. As Rich indicated, we are entering a very exciting time for our business and I would add for our financial growth prospects. To recap our Q3 performance results on most measures came in ahead of consensus expectations and reflect good execution by the team. We delivered revenue of $91.5 million. Within that content solutions revenues of $30 million reflects our third highest Q3 box office of all time on various tentpole content. Both Deadpool and Wolverine and Alien Romulus delivered the highest IMAX opening weekend box office in their respective franchise history and in China, while Hollywood film performance has been uneven, we have captured on average a 16% share of box office across Hollywood titles year-to-date, including Alien Romulus and Godzilla Kong where both titles delivered more IMAX box office in China than in domestic rest of world. Year-over-year revenues from content solutions declined 32% driven by the mix of content and compared to the prior year that was powered by the record setting box office from Oppenheimer. Turning to technology products and services, revenue of $58 million grew 3% driven by strong system installation growth that more than offset the lower box office related rental revenues resulting from the global content mix. Overall, system installations and signings both provide insight to the strong demand we are experiencing in advance of the highly anticipated 2025 and 2026 box office slates which we anticipate will drive our network growth further. During the quarter we completed 49 system installations up 63% over Q3 2023 which puts us at 88 installations year-to-date, September, a growth of 49% year-over-year. As of today, we have completed over 100 system installations. Signings to date are up to 119 through yesterday on track to exceed the 129 of full year 2023. Within new system signings the mix continues to lead towards rest of world comprising 67% of the Q3 year-to-date new system signings gross margin of 56% was below the prior year of 60% given the lower box office compared to the record setting Oppenheimer field quarter of 2023. However, we had good results across expense areas that offset this headwind or challenging compare. SG&A excluding stock based compensation was $26 million, a 16% improvement year-over-year driven by benefits from our ongoing expense initiatives as well as timing of expenses and other certain adjustments. R&D was also better year-over-year reflecting the capitalization of the investment into our new state of the art film cameras which have moved out of development upon achieving technical feasibility. In addition, bad debt provisions improved year-over-year reflecting improvements in working capital, specifically collections from exhibition customers that also helped propel us to a good cash flow result. Overall, the third quarter total consolidated adjusted EBITDA of $39 million was at a strong 42% margin, particularly considering the mix of content in the quarter. Lastly, adjusted EPS for the quarter was $0.35, consistent with last year's same quarter record. Within that Q3 adjusted tax rate was 13%, which is below our mid 20s statutory rate, driven by the jurisdictional mix of profits that led to a decrease in our evaluation allowance. This result reflects the benefits of the actions we took last quarter, which has led in part to an improvement in our effective tax rate in 2024 relative to prior years. Turning to cash flow and the balance sheet, we had strong operating cash flow in Q3 of $35 million, up 21% from the prior year, leading to $59 million through nine months, a growth of 9% year-over-year and already equalling 2023's full year operating cash flow. I am pleased to see the continued progress and growth in our cash flows. The higher year-over-year operating cash flow reflects an improvement in working capital including an increase in collections. Our capital position remains very strong at $105 million in cash and $280 million of debt excluding deferred financing costs. As a reminder, $230 million of our debt comes from our convertible senior notes due in 2026 that bear an interest rate of 0.5% per annum with a capped call leading to a $37 per share conversion price. Our current available Liquidity is over $410 million, which includes $309 million in available borrowing capacity under the company's various revolving facilities. While we are building up our cash and liquidity positions, we are also using our available capital to invest in the business. Having spent $30 million on CapEx year-to-date with $22 million of that in growth CapEx. This will continue in Q4, our historically highest growth CAPEX period. Given the higher weighting of system installations to the end of the year. We view this positively as it will strengthen our ability to achieve higher levels of box office and in turn revenue incrementality, particularly as we head into the next several years with good visibility into what is expected to be strong content slates and we continue to focus on more direct shareholder returns, having done $18 million in IMAX share repurchases year-to-date, including IMAX China. Repurchases were weighted toward the first quarter when our share price was significantly pressured following the Hollywood strikes. To conclude, our moat has never been as wide or deep. Our global scale is unmatched and growing. Our relationships with studios and filmmakers have never been stronger and varied content available for distribution on our platform has never been greater and is expanding and our technology solution for exhibitors is unequalled. Our accelerating signings and installation growth, driven by the demand for the IMAX experience by consumers, reflects our position of strength as we enter this extremely promising box office period. At the same time, we continue to see opportunity in new revenue streams to contribute to our growth and drive greater capacity utilization of our global network. Especially when you consider that one point of utilization can drive $75 million to $100 million in additional box office. Given the strength of our business model, the tailwinds in the market and our focus on executing on the opportunities before us, we continue to believe IMAX is poised to deliver strong growth, expanding margins and increased cash flow for years to come. With that, I will turn the call over to the operator for Q&A.

Operator: Thank you. At this time, we will conduct the question-and-answer session. [Operator Instructions] Our first question comes from Eric Handler with Roth Capital. Eric, please go ahead with your question.

Eric Handler: Thank you, very much and good afternoon. Rich, look, it's no surprise, at least to theatre operators that the content cycle looks really good for the next two years. But even with that being known as we get closer to next year, are you starting to hear, are you starting to get more phone calls from these theatre operators that they'd like to maybe accelerate the installation pace for your systems?

Richard Gelfond: Well, I mean Eric, I think you could look at the empirical data where this last quarter we had significantly more installs than a year ago and even our guidance on the call today where we guided to the upper end of the range. So, you know, I wouldn't get the phone calls, but I certainly read the data and the data shows that that's true. And on the other hand, as you saw, our signings are likely to run higher than last year. So also, there seems to be an increased pickup in signings. So, I think just based on the results we reported today, that's true.

Eric Handler: Okay. And then I'm sure you saw in the news earlier this week a comment Bloomberg had it that you're talking to Netflix about maybe doing exclusive with the Narnia movie that's being made there. Is anything you could say with regards to that movie or just maybe, you know how your conversations are going these days with streamers and what they're trying to do.

Richard Gelfond: I must have missed that story, Eric. Sorry, I didn't see it. In fact, as you know, directors, filmmakers, studios are all leaning into the IMAX experience in kind of another level than we've seen before. And as you know as well, we've tried different models in the past, whether it's early release or exclusive content or all kinds of things. So, I won't comment on that specific story in any way. But I would say that, you know, we're always innovating and always looking for new approaches to fantasizing content.

Eric Handler: Thank you.

Operator: Standby for our next question. Our next question comes from Chad Beynon with Macquarie. Chad?

Chad Beynon: Yep, thank you very much. Thanks for taking my question. Nice results. You've noted the healthy number of films for '25 with IMAX DNA and obviously your global box office outlook. Can you talk a little bit more about the spacing of '25, given that IMAX DNA have a slightly longer runtime? And then also related, how does the slate look in China in '25? Anything worthwhile to note there? Thank you.

Richard Gelfond: Sure. So, you're quite right, it's a little bit of an embarrassment of riches. Between May and September, the end of September, we don't have any slots available. Every single slot is filled and for the year, you know, it's as tight as I've ever seen it in terms of available times. That's a high-class problem. As you mentioned, a lot of the films were made with IMAX Cameras, with IMAX DNA. As a matter of fact, next year, 14 of our films were shot with IMAX cameras and a number internationally too, not just domestically. Also, you know, when you look at '26, to the extent a number have been announced already, it's incredibly encouraging. And I think if you wanted to look at a trend that I've seen develop in the last six months or a year, it's that people are discussing movies way farther out than they did years ago. So as a matter of fact, you know, for '27 and even '28, we've been approached about a lot of high-profile films. I think studios and filmmakers are understanding that it's IMAX release is kind of like beachfront property. If you want to reserve a place, you've really got to do it very early. And we talk a lot about our theatre backlog and what that means about future earnings. We don't talk as much about our film backlog and what that means for future earnings. But I think as you look out into the future and you talk about discounting future cash flows to the extent there's more certainty in terms of our theatre backlog and our film backlog, you should imply a lower discount rate and that's a very good thing for our business, which. So, I think that's one reason that we're so optimistic. And in China, we've just heard about a number of films that have been approved to get in. As a matter of fact, right before this call, Natasha was mentioning some of them to me. So, I'm going to turn it over to her to see if she has some of those names.

Natasha Fernandes: Hi, Chad. Yeah, so we actually, in addition to the Hollywood. So, you think about the strength of the Hollywood slate and those getting in, which this year most of them got into China. On top of that, Creation of The Gods Part 2 has been approved for Chinese New Year as well. A Writer's Odyssey, which is filmed for IMAX into the summer section of the year. And there's a few more also that have been announced. So, I think that that's good visibility. I mean, it's pretty early for Chinese New Year titles to get announced and I think that gives us essentially the confidence that China will provide a more balanced genre slate next year.

Chad Beynon: Great, thank you very much. Both. And then thinking about higher box office revenues in '25, Natasha, I know you've given some margin targets for the overall business. I think in the high 30s year-to-date, you're at 39.2. Can you just kind of help us think about the operating leverage in the content solutions, you know, business if, or both businesses for that matter, if the box office delivers as expected for '25? Thank you.

Natasha Fernandes: Sure. Chad. I mean, you're very familiar with our model, so you know that when we start to hit very high levels of box office anywhere, 250 plus, then you start to experience incrementality into our model. And so that box office, not only are we receiving payment from the studios, but then obviously from exhibitors as well for the performance of our locations. And so that creates the incrementality in the model. And then you couple that with the mix of our installations that we do throughout the year, which, as we mentioned in our prepared remarks, our installations are tracking stronger this year and we're guiding towards the higher end of the range. And so more a larger system footprint also will give us that higher box office performance as well. And I think you couple that together with the way that we've been managing the business from an operational perspective and that's where you start to think about how the EBITDA margins can continue to grow and exceed over the 40% mark.

Chad Beynon: Thank you very much.

Operator: Stand by for our next question. Our next question comes from David Karnovsky of JP Morgan. David, go ahead with your question.

David Karnovsky: All right, thank you, Rich. I want to see if you could expand a bit on the recent performance of IMAX in China. And maybe there's just the exhibition there. Generally, you know, it looks like your numbers and maybe the wider industry was down over 40% in the recent quarter over the summer. Is this economic, is the film quality, or there are other kind of factors? I don't know. What are you hearing from your staff on the ground there?

Richard Gelfond: Yes, I think we think it's a combination of things, David. So obviously, the economy overall has been pretty weak this year in China. And you noticed recently the new government measures that have taken effect. Monetary policy, policy towards the real estate, sector, fiscal policy. And again, it's hard enough to predict a company, let alone a country, but it looks like some of these things, you're certainly designed to focus on the consumer. As you know, box office in the movie business is very important to the Chinese government because almost all of the 80,000 screens are, a lot of them anchor big real estate developments. And I think one of the focuses of the government is to get people, you know, to go to malls and to do shopping and help the domestic economy. So clearly that was one part of it. As I think Natasha said before, that the kinds of films being released and how close they were or weren't to the IMAX genre played a role. I still think there's a little bit of a Covid hangover because a lot of the films were released in '23, but less films released in '24. On the bright side, a lot of films that you wouldn't have expected to get into China, like Deadpool and like Joker, which, you know, I just don't fit the typically more conservative profile have gotten in. So, I think that's a signal that the government wants more films in and it's part of their overall policy. And as Natasha just said a minute ago, they've dated a lot of local language films for next year, which they don't typically do that far out. So, you know, predicting movies, like predicting stocks, you know, not a very exact science. But when we and we're just in the process of going through our budget, but when we look at next year compared to this year, we think it will be significantly better than this year.

David Karnovsky: And then, Natasha, the SG&A is noted down 16% in the quarter. I think you called out some timing benefits. I don't know if you can quantify those so we can get a sense of more of the underlying rate and then just any guidance for how to think about that R&D line kind of going forward? I wouldn't expect it to be negative on a go forward basis.

Natasha Fernandes: Hi, David. Yeah, so the R&D, I'll address that first. You're correct. It wouldn't be negative on a go forward basis. We typically do have R&D expense on each quarter. So, for your run rates, as you think about them, I would be looking at an expense. And essentially, we just did our annual assessment of technical feasibility on our film camera project and we achieved the milestones needed. And that's why you saw the credit in the quarter. When you're looking at SG&A, we actually had year-over-year, we had last year we had over $3 million of the transaction costs related to the privatization and so China privatization. So that's really what you're seeing in most of the variance year-over-year. So, when you're thinking through a run rate, I mean, our historical run rate is pretty predictive of the future. I wouldn't be thinking of it in any different manner, but I think we've gotten some real wins on the operational efficiency side. And then timing of expenditures, there's still another quarter to go in the year and so timing of expenditures. Sometimes we delay some of our expenditures on consultants or fees or marketing and see where we're landing for the year because we have the opportunity to make decisions that will help us strengthen our financials as we look year-over-year.

David Karnovsky: Thank you.

Operator: Stand by for our next question. Our next question comes from Omar Mejias with Wells Fargo. Omar, go ahead with your question.

Omar Mejias: Good evening and thank you for taking my question. Rich, maybe first, I noticed you guys kept the 2024 IMAX box office unchanged flat year-over-year, despite 3Q being impacted by China weakness. And 4Q off to a slow start with Joker and Venom. Are you guys still confident in achieving this guidance and there's any films are you excited in 4Q that could potentially offset the slower start?

Richard Gelfond: Yeah, I mean, you know, this is the third time I've said it. It's a movie business. Pretty hard to predict where things are going to come out. But when you look at the year going forward, we are incredibly excited about the Thanksgiving period around that. We've got Gladiator and Wicked and Moana too. And Wicked came out of the box really strong with pre sales, which is not surprising. There's a wide following for that IP as you know, the show has played for a decade and it's the kind of property people had circled on their calendar and came out and bought a lot of tickets. And then Gladiator has taken a little while to catch up. But actually, it's really come on strong recently and it stars Denzel Washington and it's, it's big. The early buzz on it is extremely good. The subject matter is very conducive to IMAX and we're leaning in pretty hard on that, as is Paramount Studio, that's leaning into the IMAX of it all. And then Moana, some people think that's going to be one of the highest grossing movies of the year. So, we have the ability around Thanksgiving, our programming to some extent with which movies are working and which aren't. You know, you only commit typically for the first week or maybe two weeks. So, I think that flexibility gives us a very good feeling about what's going on around the Thanksgiving time. You know, all the time there are movies that don't work, but this time, you know, out of that group, I'm quite confident that that period is going to be very strong for us. And then at the end of the year, you have Mufasa and we have precedent for that. So, we can see what the Lion King did. And typically, in IMAX, there are pretty good numbers coming out of that. So, with that said, you're just not sure where it's going to end up. But we feel pretty good about our slate for the rest of the year.

Omar Mejias: That's very helpful. And Natasha, you mentioned improvements to capacity utilization across your system. Can you elaborate some of the internal initiatives that you guys have put in place to drive utilization higher? What's the opportunity set from a percentage standpoint at IMAX over the next few years? Thanks.

Natasha Fernandes: Sure, Omar. So, we've been talking about alternative content for quite some time and we've actually made a lot of traction this year over prior years. And the team's been put together in a way that they are synergistically working among the organization and within the organization, which I think earlier this year we talked about the fact that we made some restructurings and team changes in order to create that efficiency in the organization. And so that team has been working really hard on not only you saw the Blue Angels doc earlier this year, but then we've done lots of alternative content between the concert films and moving into sports. This week we're doing League of Legends as well, which is new and in China, and actually China is in the finals against a Korean team. And so, I think we're looking at about the ability to do about 150 locations. And so, thinking about what are all those opportunities and when you pull them together coupled with different models. So not everything will be straight box office getting the ability to say, okay, do you do flat fee deals as well and other types of models to make sure in the end, regardless of where box office is, you're still strengthening your financials and giving yourself other opportunities to create returns. And so, using those initiatives, I think that that's where we'll continue to spend time. And then of course you would have heard in Richard's remarks as well that we've hired a chief content officer and that that position is essentially to set the strategy for how do we create opportunities for ourselves on the content side and really make an impact on that side. Rich?

Richard Gelfond: Omar, I'd also like to add, you know, we're out in LA now that it's hard for me to see people who don't say, you know, wow, what about the sphere? Wow, what about Qasem? You know, isn't amazing all this alternative content coming out. But as you know, these things are really high CapEx kind of experiences and I, you know, I think they're really good and I think there's a future for them. But you know, IMAX has 1800 theatres sitting throughout the world and not only do we show movies, but we show awe inspiring experiences and alternative content. And I had a much lower capital cost and entry point. So, I think over time, you know, you'll see us really benefit in terms of utilization from that diversification content.

Omar Mejias: It's very helpful guys, thank you very much.

Operator: Our next question comes from David Joyce with Seaport Research Partners. David, go ahead with your question.

David Joyce: Thank you. The system sales revenue was up very steadily in the quarter. System rentals were down. Do you still have basically an agnostic view as to which strategy employ or is one of them quicker in the event that these theatres are looking to accelerate their being on the IMAX network?

Natasha Fernandes: Hi David. I think a mix between the systems is still our strategy. However, as you look at the slate in the next few years, I mean, is there an opportunity to install, therefore get a higher return on the rental side? That is an opportunity before us. And also, when you're thinking about different countries and the operators that exist in those countries and their balance sheets, I mean, as you know, our balance sheet sheet is very strong and we have the ability to put up the capital for that higher return. And I think that's where we have some opportunity before us. And yes, you're going to have ebbs and flows like this quarter where the rentals revenue was lower because box office was lower. But then you have other quarters like last year's Oppenheimer first quarter this year with Dune, of course we have Avatar next year and the film for IMAX Slate next year. And so, I really think you got to look at it in the full portfolio approach of an annual view and look at how strong the rentals revenue can perform for us and really give us that outperformance and incrementality in the model.

David Joyce: Great, thank you.

Operator: Stand by for our next question. Our next question comes from Patrick Sholl with Barrington Research. Patrick, please go ahead with your question.

Patrick Sholl: Hi, good afternoon. I just had a question on like new screen installations. I was wondering if there's any sort of like lag between a new screen install and getting to like a ramp up in box office. I was wondering if there's like any differences across countries.

Richard Gelfond: There actually is, you know, some. We've done some research into how quickly things ramp up because obviously when you first open, there's some opening kind of publicity around it and there is a seasoning period for theaters between when they open and when they hit their point. But they're widely differentiated in parts of the world and you know, even within territories, you know what the particular locations are. So, we have it and we look at it, but frankly, there are no meaningful trends that I can give you other than to say that, you know, when things open, it takes a little while until they hit their peak performance.

Patrick Sholl: Okay. Have you noticed that timeframe shortening after the pandemic?

Richard Gelfond: We haven't really done research in that direction, so I can't say. But I could certainly say when people open around a major movie at a time like that, so many people see it that it really accelerates the word of mouth and shortens it. So, I'm hoping as we're in the fourth quarter and next year, all the promising content, that that period will get shorter. But I haven't studied it empirically.

Patrick Sholl: Okay, thank you.

Operator: Our next question comes from Stephen Laszczyk with Goldman Sachs. Steven, go ahead with your question.

Stephen Laszczyk: Great, thanks for taking the questions. Two if I could. First on local Language, maybe for Rich, could you update us on the medium-term outlook for the local language film supply? What are you hearing from some of your key partners out in some of those key international markets in terms of their production plans? Where do you see Film Supply today in some of those markets and where do you think it can get to over the next few years? And then second maybe on CapEx for Natasha. I think growth CapEx came in around $12 million in the quarter. I think you mentioned the install calendar being a little back and weighted with 4Q. Any more context you could add on 4Q growth CapEx and then perhaps anything on '25 as we think about you executing against the installation pipeline next year. Thank you.

Richard Gelfond: So, Stephen, as you know, last year was around local language was around 20% of our total box office. This year it's marginally lower, but in the same kind of ballpark. And my guess is the reason it's a little bit lower is because the Chinese box office was some more challenged this year. And again, as we go into next year where we expect a more robust Chinese box office, I would think it would settle around that 20% level or higher. There's a lot of activity going on with studios and filmmakers from around the world and we continue to have new countries opening up. So, you know, I think I might have mentioned in my speech, but we had this film called I’m Hero in Korea concert film which was just did exceptionally well and I think when you have kind of those new territories and the new one offs, they really boost the amount of inquiries that comes in. We're in France now, we're working on actually an original production that's likely to be released only in IMAX and then elsewhere. So you know, I really don't feel, you know, better or worse for it. I think it'll continue its Trend. So, in 1919 I'm guessing, but I think it was less than half what it was as a percentage, Stephen, as it was in '23. And I think that trend will continue.

Natasha Fernandes: Hi Stephen. On the CapEx side, year-to-date we're about $20 million for growth CapEx. And I think, you know, if you looked at historical pre pandemic years, we ranged somewhere between $30 million to $40 million historically. And you know, I think that's where the opportunity is that we do have the strong balance sheet that I talked about earlier and the ability to get higher returns as well. Especially when you look at the slate as it stands right now. And so, we do have the ability to do that. The other part is as we look out towards next year, if you looked at historical patterns of installations, we generally have a historical mix of about 50 50, we've stayed pretty strong to that. But there are years that could weigh more heavily to JV CapEx. It really depends on who we're rolling out with from an exhibitor side, which locations or countries, geographic places in the world and the ability to look at where do we want to spend our dollars? And I know we've had this conversation before, but it's about where is the place you want to spend your dollar? Is it in a region that can give you a higher per screen average or and what do you focus on? And so, our teams, and we've talked about our theatre team, they do a biweekly call. They really think through and plan it out as much as they can to be able to say what's going to give us the most return and try and work with exhibitors to push those forward. And I think that's where we've delivered and we continue to. And I'm confident we'll continue.

Stephen Laszczyk: Great. Thank you both.

Operator: Our next question comes from Mike Hickey with The Benchmark Company. Mike, go ahead with your question

Mike Hickey: Hey, thank you. Hey, Rich, Natasha, Jennifer, great quarter, guys. Thanks for taking our questions. Just Natasha, Rich, just clarification on your '25 guide. I think it's pretty much exactly the same, but you threw in the $1.2 billion. Natasha, was that your original assumption when you guided revenue growth to be high single digit in 2025 or has that changed?

Natasha Fernandes: Hi Mike, we actually didn't give out a guide for next year's box office when we did the look through guidance earlier this year. We just commented on high single digits for revenue growth. And so that revenue growth was based on a holistic view of our entire P&L. And I think that that's where we look at the different levers. And right now, we feel confident in giving out the $1.2 billion. And I'm sure that at a later date we'll come back with other guidance metrics as we do each year. Okay, great. I guess the next question, Rich, more superhero fatigue on how many times you've probably heard that. But it sort of popped up here again recently. And I know Avengers and other sort of superhero fanboy film experiences have been important and will be important when you think about growth in '26 and '27. So how are you thinking about that genre, I guess in particular and what offsets you have if it is weaker than it has been historically?

Richard Gelfond: I mean, when you look at our schedule for the next two years, you have what's been announced so far. You have Dune 3. You have the new Christopher Nolan movie. You have Formula one. You know, none of those involve superheroes except for the directors who are all superheroes. But you know, I just think we, you have Our alternative content, local language. You know, I don't think we're overemphasizing superheroes, and I think the death of the superhero and fatigue was. Has already been proven wrong. You look at Deadpool and how well that did. I think, you know, what caused the previous superhero fatigue was probably streaming, which contributed so much content. Not, you know, along with the movies that were coming out at that time, the market was flooded with content. But I think the slate is really well balanced going forward. And, you know, I've spent a lot of time with our studio partners and our filmmakers and, you know, going in to our forecast going forward, and our optimism is, I think these films are going to perform extremely well. You know, there's always one or two that don't work because it's the movie business and not everything works. But I don't believe there's superhero fatigue right now. I mean, as a matter of fact, let's go into Thanksgiving where I'm incredibly optimistic, where you have Wicked and Moana and you have Gladiator, and none of those are superheroes. And unless Mufasa flies or something, I don't think he's a superhero either. So I just don't think that's. I don't think it's a real issue.

Mike Hickey: Nice. Rich, real quick, you mentioned Christopher Nolan's going to get some new tech. Are those the new cameras that are now sort of going out into the field, or is that something else?

Richard Gelfond: I think we're going to have to wait until he wants to talk about it.

Mike Hickey: Okay, thanks, Rich. Take care, guys.

Operator: This concludes the question-and-answer session. I would now like to turn it over to Rich Gelfond for closing remarks.

Richard Gelfond: I don't have a lot to say other than I think the quarter really demonstrated something we talk about all the time, which is revenue diversification. You know, we diversified around the world in sources of revenues. So, you know, China didn't have a great third quarter, but North America had a really good third quarter. You know, I think we talk about diversification in terms of different kinds of content coming in. So, some things that perform very well are in the mix are League of Legends, the Olympics, all kinds of different music content. Our documentary Blue Angels was very successful for us this year. So, I think, you know, that's another kind of diversification. And I think throughout that our brand continues to gain resonance and our market share generally keeps going up and our indexing does very well. So, I feel really good about it. As I've said too many times, '25 and '26 look really strong. So, you know, I think this quarter and it's the spotlight on diversification also, I'd say installs, high number of installs. You know, there's lots of ways we're diversified. So, I think the more people understand about our company and the revenue sources, the more people will understand our growth story. Anyway, thank you.

Operator: Thank you for your participation in today's conference. This does conclude the program. You may now disconnect.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.